España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Merck
MKKGY
OTCPK
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$29.53
0.45
1.55%
At close: -
$29.51
-0.02
-0.07%
After Hours: Nov 22, 4:22 PM EDT
Get Report
Comment
Merck (MKKGY) Forecast
News
Earnings
Merck (MKKGY) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Merck (OTC:MKKGY) Stock
Merck Stock (OTC: MKKGY)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, March 04, 2024
C4 Therapeutics Has Entered Into A License Ag...
Benzinga Newsdesk
Tuesday, December 12, 2023
Pfizer Clears Required Regulatory Hurdles To Complete $43B Seagen Acquisition
Vandana Singh
Wednesday, December 06, 2023
Merck Germany's Two Pivotal Trials Flunk In Multiple Sclerosis
Vandana Singh
Tuesday, September 26, 2023
Life Sciences Player Repligen's Strategic European Acquisition - What It Means for Investors
Vandana Singh
Wednesday, September 20, 2023
Exscientia And Merck Collaborate On AI-Driven...
Benzinga Newsdesk
Thursday, August 03, 2023
Merck Germany Reports 5% Decline In Q2 Sales, Expects More Decline In 2023
Vandana Singh
Wednesday, July 26, 2023
Novo Nordisk's Obesity Drug Saxenda Not Included In WHO's Essential Drug List
Vandana Singh
Tuesday, June 20, 2023
Abcam Downgrade: Analyst Trims Expectations Amid Activist Investor Engagement and Potential Bid Anticipation
Vandana Singh
Tuesday, April 18, 2023
Analyst Says Nektar Therapeutics' Rezpeg Prioritization Likely to Spark Investor Questions
Vandana Singh
Wednesday, April 12, 2023
FDA Issues Partial Clinical Hold On Merck Germany's Multiple Sclerosis Study
Vandana Singh
Monday, March 27, 2023
Merck Germany Regains Exclusive Global Rights To Cancer Drug From Pfizer
Vandana Singh
Thursday, March 23, 2023
Incyte Would Now Compete With Merck, Pfizer As Its Skin Cancer Treatment Scores FDA Accelerated Approval
Vandana Singh
Friday, January 20, 2023
With Upcoming Ovarian Cancer Data, Analyst Sees 100% Upside For Mersana Therapeutics
Vandana Singh
Tuesday, January 03, 2023
PDS Biotech, Merck Germany Enter Licensing Pact For Investigational Cancer Treatment
Vandana Singh
Friday, December 23, 2022
Mersana Inks Cancer Therapy Development Deal With Merck Germany
Vandana Singh
Wednesday, October 19, 2022
SpaceX Starlink's New In-Flight Connectivity Service, Amazon's NY Workers Reject Union, Celsius Network Faces Several Federal Investigations: Top Stories Wednesday, Oct. 19
Vandana Singh
Germany's Merck Slapped With Formal French Investigation Related To Its Thyroid Drug
Vandana Singh
Tuesday, October 11, 2022
PDS Biotech Highlights Expanded Data From PDS0101 Triple Combination Trial In HPV-Positive Cancers
Vandana Singh
Thursday, June 02, 2022
Oncolytics Reports Partnering With Biopharma Industry Leaders To Fast-Track Immunotherapy Treatment
Rachael Green
-
Sponsored
Tuesday, May 31, 2022
Germany's Merck To Launch Semiconductor Base In China
Anusuya Lahiri
Wednesday, February 16, 2022
Oncolytics Reports Foothold In Chinese Pharmaceutical Market With Latest Breast Cancer Clinical Trials
Rachael Green
-
Sponsored
Monday, January 24, 2022
TSMC Looks To Hire Over 8,000 People In 2022
Anusuya Lahiri
Thursday, January 13, 2022
This Biotech Is Working With Pfizer, Merck KGaA, Roche, and Other Leaders To Develop a Better Standard of Care for Breast Cancer
Rachael Green
-
Sponsored
Thursday, November 18, 2021
The Daily Biotech Pulse: Pfizer Strikes $5.29B COVID Pill Supply Deal With US, Roche's Spark Therapeutics Reports Positive Gene Therapy Readout, EDAP Earnings
Shanthi Rexaline
Thursday, September 30, 2021
GlaxoSmithKline, Merck KGaA End $4B Cancer Drug Pact
Vandana Singh
Tuesday, September 21, 2021
Nektar, Merck Germany, Pfizer Join Forces For Mid-Stage Bladder Cancer Study
Vandana Singh
Tuesday, August 24, 2021
Merck KGaA Pulls Plug On GSK-Partnered Cancer Drug Trial
Vandana Singh
Tuesday, June 01, 2021
Sutro Biopharma Receives Undisclosed Milestone Payment Under Bispecific ADC Collaboration with Merck
Vandana Singh
Immutep, Merck Germany Team Up for Eftilagimod/Bintrafusp Combo Trial In Solid Tumors
Vandana Singh
Friday, May 14, 2021
Gene Therapy Player Vera Therapeutics Prices IPO Well Below Range At $11/Share
Vandana Singh
Monday, May 10, 2021
UK's NICE Provisionally Rejects Coverage Of Pfizer-Merck KGaA's Bavencio As First-Line Therapy For Bladder Cancer
Vandana Singh
Friday, April 09, 2021
The Daily Biotech Pulse: Negative Regulatory Tidings For Provention Bio, Celcuity Soars On In-licensing Deal, 2 IPOs
Shanthi Rexaline
Wednesday, April 07, 2021
Novartis Taps Artios In Discovery Pact To Enhance Radioligand Portfolio
Vandana Singh
Thursday, March 18, 2021
Exelixis' XL092 To Be Tested In Combination With Bavencio In Urothelial Carcinoma
Vandana Singh
Wednesday, March 17, 2021
Germany's Merck Invests In French Facility For Single Use Products
Vandana Singh
Tuesday, November 17, 2020
13 International Companies Giving Public Investor Presentations This Week
Spencer Israel
Wednesday, July 01, 2020
The Daily Biotech Pulse: T2 Biosystems Launches COVID-19 Test, Akero Aces Midstage NASH Study, Aravive Added to Russell Indexes
Shanthi Rexaline
Tuesday, March 24, 2020
Stocks That Hit 52-Week Highs On Tuesday
Benzinga Insights
Tuesday, March 17, 2020
10 International ADR Companies That Are Conducting Virtual Investor Presentations This Week
Spencer Israel
Wednesday, February 19, 2020
Stocks That Hit 52-Week Highs On Wednesday
Lisa Levin
Friday, January 24, 2020
Stocks That Hit 52-Week Highs On Friday
Lisa Levin
Friday, January 10, 2020
Stocks That Hit 52-Week Highs On Friday
Lisa Levin
Thursday, January 09, 2020
Stocks That Hit 52-Week Highs On Thursday
Lisa Levin
Wednesday, November 20, 2019
The Daily Biotech Pulse: Endo's Cellulite Treatment Accepted For Review, Diffusion Pharma Reports Positive Glioblastoma Data
Shanthi Rexaline
Thursday, November 07, 2019
The Daily Biotech Pulse: Obseva Sinks On Adverse Clinical Readout, BioNano Surges On Saphyr Adoption, 2 IPOs
Shanthi Rexaline
Wednesday, May 15, 2019
The Daily Biotech Pulse: FDA Greenlights Pfizer-Merck KGAa's Kidney Cancer Combo Treatment, Adcom Disappointment For Daiichi
Shanthi Rexaline
Tuesday, May 14, 2019
Pfizer, EM Serono Announce FDA Approves BAVENCIO Plus INLYTA Combination for Patients with Advanced Renal Cell Carcinoma
Charles Gross
Friday, April 12, 2019
Merck Signs Versum Buyout Deal; Entegris Receives Termination Payment
Mary Meldrum
Wednesday, March 20, 2019
Merck KGaA, Pfizer Announce Discontinuation of Phase III JAVELIN Ovarian PARP 100 Trial in Previously Untreated Advanced Ovarian Cancer
Charles Gross
Sunday, February 17, 2019
Pfizer Announces Pivotal Phase III Data for BAVENCIO Plus INLYTA in Advanced RCC Published in the New England Journal of Medicine
Charles Gross
Show More
